Limb-girdle muscular dystrophy: genes and variants
Explore variant evidence for Limb-girdle muscular dystrophy across 11 analyzed proteins (SGCA, FKRP, LAMA2, SGCD, HMGCR and 6 more). Linked ClinVar records include 93 pathogenic or likely pathogenic variants, 334 variants of uncertain significance and 98 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Limb-girdle muscular dystrophy
SGCA: Alpha-sarcoglycan
It is part of the sarcoglycan complex that stabilizes the muscle-cell membrane during contraction by linking dystrophin-associated structures to extracellular matrix. Biallelic loss-of-function variants cause limb-girdle muscular dystrophy R3 with progressive proximal weakness and possible cardiomyopathy.
61 ClinVar pathogenic / likely pathogenic and 156 uncertain variants in SGCA have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
FKRP: Ribitol 5-phosphate transferase FKRP
It is required for proper glycosylation of alpha-dystroglycan, enabling muscle fibers and other cells to attach effectively to extracellular matrix. Biallelic pathogenic variants cause dystroglycanopathies ranging from limb-girdle muscular dystrophy to severe congenital muscular dystrophy with brain or eye involvement.
20 ClinVar pathogenic / likely pathogenic and 39 uncertain variants in FKRP have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
LAMA2: Laminin subunit alpha-2
It links cells to surrounding extracellular matrix through dystroglycan and integrins. Biallelic loss-of-function variants cause LAMA2-related muscular dystrophy, ranging from severe congenital disease to later-onset limb-girdle weakness.
4 ClinVar pathogenic / likely pathogenic and 87 uncertain variants in LAMA2 have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
SGCD: Delta-sarcoglycan
Delta-sarcoglycan is part of the dystrophin-associated complex that links the muscle-cell cytoskeleton to the extracellular matrix. Variants can cause limb-girdle muscular dystrophy and cardiomyopathy.
2 ClinVar pathogenic / likely pathogenic and 130 uncertain variants in SGCD have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
It controls the rate-limiting step of the mevalonate pathway and therefore strongly regulates endogenous cholesterol production. Statins lower LDL cholesterol by inhibiting this activity, causing the liver to increase LDL-receptor-mediated clearance from blood.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in HMGCR have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
LMNA: Prelamin-A/C
The gene product produces lamins A and C, structural proteins that form the nuclear lamina beneath the inner nuclear membrane. Lamins help maintain nuclear shape and organize chromatin, and LMNA variants are associated with muscular dystrophy, cardiomyopathy, lipodystrophy, and premature-aging syndromes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LMNA have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
DES: Desmin
Its desmin filaments mechanically integrate sarcomeres with the nucleus, mitochondria, and cell junctions in striated muscle. Pathogenic variants cause desmin-related myopathy and can produce cardiomyopathy, conduction disease, and skeletal-muscle weakness.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in DES have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
L1CAM: Neural cell adhesion molecule L1
It promotes neuronal adhesion, axon guidance, neurite growth, and fasciculation during nervous-system development. Loss-of-function variants cause L1 syndrome, encompassing X-linked hydrocephalus, MASA syndrome, spastic paraplegia, and variable intellectual disability.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in L1CAM have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
TUBA1A: Tubulin alpha-1A chain
An alpha-tubulin chain that pairs with beta-tubulin to build microtubules. Microtubules provide tracks for transport and help shape dividing and migrating cells, making TUBA1A especially important for fetal brain development.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TUBA1A have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
DYSF: Dysferlin
It is required for calcium-dependent membrane repair in skeletal muscle and contributes to vesicle fusion after sarcolemmal injury. Biallelic loss-of-function variants cause dysferlinopathies, including limb-girdle muscular dystrophy R2 and Miyoshi distal myopathy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DYSF have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
TTN: Titin
Its enormous titin polypeptide spans much of the sarcomere and provides passive elasticity, structural alignment, and mechanosensing in striated muscle. Truncating variants are among the most common genetic causes of dilated cardiomyopathy, while other variants cause diverse skeletal and cardiac myopathies.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in TTN have source records linked to Limb-girdle muscular dystrophy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): COL6A3, CAV3, COL6A2, FLNC, NEB, POLG, RYR1, SCN4A and 1 more.
ClinVar pathogenic and likely pathogenic variants linked to Limb-girdle muscular dystrophy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SGCA R81C | 81 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R34C | 34 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA I103V | 103 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R34H | 34 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA L66H | 66 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA L89F | 89 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R98C | 98 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA P205S | 205 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R77C | 77 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA Y90C | 90 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R98H | 98 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA P205H | 205 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R221C | 221 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R221P | 221 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA V242F | 242 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA L31P | 31 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA S82R | 82 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA G68E | 68 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA A107V | 107 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA V247M | 247 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA R284C | 284 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA G168R | 168 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| SGCA D234N | 234 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| FKRP P89L | 89 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP P89A | 89 | Lumenal | Pathogenic / likely pathogenic (★★) |
| SGCA R74W | 74 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA I103T | 103 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FKRP R54W | 54 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP R54G | 54 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP R275C | 275 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP P316T | 316 | Zinc finger loop | Pathogenic / likely pathogenic (★★) |
| FKRP G345A | 345 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP I478T | 478 | Lumenal | Pathogenic / likely pathogenic (★★) |
| SGCA G91S | 91 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA R98S | 98 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA V242A | 242 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FKRP Y307N | 307 | Zinc finger loop | Pathogenic / likely pathogenic (★★) |
| SGCA V32A | 32 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA L76F | 76 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA E137K | 137 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FKRP P117R | 117 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP V300A | 300 | Zinc finger loop | Pathogenic / likely pathogenic (★★) |
| FKRP V405L | 405 | Lumenal | Pathogenic / likely pathogenic (★★) |
| FKRP P462S | 462 | Lumenal | Pathogenic / likely pathogenic (★★) |
| SGCA I124T | 124 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SGCA L173P | 173 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FKRP A157P | 157 | Lumenal | Pathogenic / likely pathogenic (★★) |
| LAMA2 M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| LMNA Y376H | 376 | IF rod | Pathogenic / likely pathogenic (★★) |
| SGCD E261K | 261 | Extracellular | Pathogenic / likely pathogenic (★★) |
| TUBA1A R402C | 402 | Pathogenic / likely pathogenic (★★) | |
| LAMA2 R1508K | 1508 | Laminin EGF-like 16 | Pathogenic / likely pathogenic (★★) |
| SGCA M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| SGCA V196I | 196 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FKRP P89S | 89 | Lumenal | Pathogenic / likely pathogenic (★) |
| SGCA P73S | 73 | Extracellular | Pathogenic / likely pathogenic (★) |
| SGCA G201S | 201 | Extracellular | Pathogenic / likely pathogenic (★) |
| SGCA P73R | 73 | Extracellular | Pathogenic / likely pathogenic (★) |
| SGCA R74P | 74 | Extracellular | Pathogenic / likely pathogenic (★) |
| SGCA R81S | 81 | Extracellular | Pathogenic / likely pathogenic (★) |
Showing 60 of 93.
Uncertain variants prioritized for review in Limb-girdle muscular dystrophy
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SGCA P73L | 73 | Extracellular | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; P73R at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.965 |
| SGCA P70S | 70 | Extracellular | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; P70R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.954 |
| SGCA G68R | 68 | Extracellular | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; G68E at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.813 |
| SGCA C232W | 232 | Extracellular | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; C232Y at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.776 |
| SGCA G91C | 91 | Extracellular | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; G91S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.94 |
| SGCA R81H | 81 | Extracellular | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R81S at the same position is pathogenic; REVEL 0.855 |
| SGCA R110Q | 110 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R110L at the same position is pathogenic; REVEL 0.784 |
| SGCA E137Q | 137 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; E137G at the same position is pathogenic; seen in 6.3e-06 of gnomAD DNA copies; REVEL 0.766 |
| SGCA P205L | 205 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P205H at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.718 |
Which prediction tools work for Limb-girdle muscular dystrophy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 81 out of 100
- PolyPhen-2: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 78 out of 100
- CADD: 76 out of 100
- ESM1b (LLR): 74 out of 100
- phyloP: 70 out of 100
- SpliceAI: 63 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 62 out of 100
- Pangolin: 30 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Walker-Warburg congenital muscular dystrophy also has ClinVar records linked to FKRP variants; they fall partly in the same places as the Limb-girdle muscular dystrophy variants (44 pathogenic / likely pathogenic).
- Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 also has ClinVar records linked to FKRP variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (14 pathogenic / likely pathogenic).
- Muscular dystrophy-dystroglycanopathy also has ClinVar records linked to FKRP variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (6 pathogenic / likely pathogenic).
- LAMA2-related muscular dystrophy also has ClinVar records linked to LAMA2 variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (11 pathogenic / likely pathogenic).
- Merosin deficient congenital muscular dystrophy also has ClinVar records linked to LAMA2 variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (9 pathogenic / likely pathogenic).
- Tubulinopathy also has ClinVar records linked to TUBA1A variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (101 pathogenic / likely pathogenic).
- Lissencephaly due to TUBA1A mutation also has ClinVar records linked to TUBA1A variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (62 pathogenic / likely pathogenic).
- Tubulinopathy-associated dysgyria also has ClinVar records linked to TUBA1A variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (6 pathogenic / likely pathogenic).
- TUBA1A-associated tubulinopathy also has ClinVar records linked to TUBA1A variants; they fall mostly in different places as the Limb-girdle muscular dystrophy variants (3 pathogenic / likely pathogenic).
Diseases related to Limb-girdle muscular dystrophy
- Dilated cardiomyopathy, also linked to DES, LMNA, SGCD and TTN
- Muscular dystrophy, also linked to FKRP, LAMA2 and LMNA
- Familial isolated dilated cardiomyopathy, also linked to DES, SGCD and TTN
- Primary dilated cardiomyopathy, also linked to DES and LMNA
- Arrhythmogenic right ventricular dysplasia, also linked to DES and LMNA
- Muscular dystrophy due to LMNA mutation, also linked to LAMA2 and LMNA
- Primary familial dilated cardiomyopathy, also linked to DES and LMNA
- Familial hypercholesterolemia, also linked to HMGCR
- Hypertrophic cardiomyopathy, also linked to TTN
- Hereditary spastic paraplegia, also linked to L1CAM
- Charcot-Marie-Tooth disease, also linked to LMNA
- Alzheimer disease, also linked to HMGCR
Frequently asked questions
Which genes have records linked to Limb-girdle muscular dystrophy?
This view contains 11 analyzed proteins: SGCA, FKRP, LAMA2, SGCD, HMGCR and 6 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 93 pathogenic or likely pathogenic variants, 334 variants of uncertain significance and 98 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 703 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center